Abstract:<b>The drug-drug interaction (DDI) between Amiodarone (AMIO) and Sofosbuvir (SOF), a direct-acting Hepatitis-C NS5B Nucleotide Polymerase Inhibitor, has been associated with severe bradyarrhythmia in patients. Recent Cryo-EM data has revealed that this DDI occurs at the α-subunit of L-type Cav channels (LTCC), with AMIO binding at the fenestration site and SOF (or MNI-1: analog of SOF) binding at the central cavity of the conductance pathway. In this study, we investigated the DDI between 21 AMIO analogs, including Dronedarone (DRON), and MNI-1 (or SOF) in hiPSC-CMs (human induced pluripotent stem cell-derived cardiomyocytes) and hCav1.2 models. Our findings indicate that among the tested AMIO analogs in hiPSC-CMs at clinically relevant concentrations, only three analogs (AA-9, AA-10, and AA-17) were able to effectively substitute for AMIO in this DDI with 1 µM MNI-1. This highlights the importance of the diethyl amino group of AMIO for interacting with MNI-1. In the hCav1.2 model, desethylamiodarone (AA-12) demonstrated synergy with 90 µM MNI-1, while three other analogs with modifications to the position of the diethyl amino group or removal of iodo groups showed weaker synergy with 90 µM MNI-1. Interestingly, DRON did not exhibit any interaction with 270 µM SOF or 90 µM MNI-1, suggesting that it could safely replace AMIO in patients requiring SOF treatment, other clinically relevant differences considered. Overall, our functional data align with the Cryo-EM data, highlighting that this DDI is dependent on the structure of AMIO and cardiomyocyte resting membrane potential.</b> <b>Significance Statement</b> Our findings point to specific residues in the AMIO molecule playing critical role in the drug-drug interaction between AMIO and MNI-1 (SOF analog), confirming Cryo-EM results. Applied at clinically relevant AMIO's concentrations or projected MNI-1's concentrations at the resting potentials mimicking the SA node, this DDI significantly slowed down or completely inhibited the beating of hiPSC-CMs. Finally, these in vitro results support the safe replacement of AMIO (Cordarone®) with DRON (Multiq®) for patients requiring SOF treatment, other clinical caveats considered.

Exploring the Interplay between Extracellular pH and Dronedarone's Pharmacological Effects on Cardiac Function

Interaction of the antiarrhythmic drug Amiodarone with the sodium channel Nav1.5 depends on the extracellular pH

Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone.

Dronedarone's inhibition of If current is the primary mechanism responsible for its bradycardic effect

Extracellular acidification reveals the antiarrhythmic properties of amiodarone related to late sodium current-induced atrial arrhythmia

Proarrhythmic and Antiarrhythmic Effects of Multiple Ion Channel Inhibitors Modulated by the Late Sodium Current

Site-directed deuteration of dronedarone preserves cytochrome P4502J2 activity and mitigates its cardiac adverse effects in canine arrhythmic hearts

Late Sodium Current Contributes To The Reverse Rate-Dependent Effect Of I-Kr Inhibition On Ventricular Repolarization

Modulation of the Late Sodium Current by ATX-II and Ranolazine Affects the Reverse Use-Dependence and Proarrhythmic Liability of IKrblockade

Effects of Pharmacological Gap Junction and Sodium Channel Blockade on S1S2 Restitution Properties in Langendorff-perfused Mouse Hearts

Structural basis for inhibition of the cardiac sodium channel by the atypical antiarrhythmic drug ranolazine

Role of Late Sodium Current in Modulating the Proarrhythmic and Antiarrhythmic Effects of Quinidine.

A general mechanism for drug promiscuity: Studies with amiodarone and other antiarrhythmics

Progress on Dronedarone-a New Anti-Arrhythmia Drug

Distinctive Property and Pharmacology of Voltage-Gated Sodium Current in Rat Atrial Vs Ventricular Myocytes

Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.

Pharmacological Modulation by Low Molecular Weight Heparin of Purinergic Signaling in Cardiac Cells Prevents Arrhythmia and Lethality Induced by Myocardial Infarction

Effects of DDPH on Reperfusion Induced-Arrhythmia and Cardiac Α-Adre Noceptors

Effects of ranolazine at therapeutically relevant concentration on electrical activity of human atrial myocytes

Structure Activity Relationship and Voltage Dependence for the Drug-Drug Interaction between Amiodarone Analogs and MNI‐1 at the L-type Cav Channel

Kir1.1 and SUR1 are not implicated as subunits of an adenosine triphosphate-sensitive potassium channel involved in diazoxide cardioprotection